196 related articles for article (PubMed ID: 31362723)
1. Neutrophil elastase as a biomarker for bacterial infection in COPD.
Thulborn SJ; Mistry V; Brightling CE; Moffitt KL; Ribeiro D; Bafadhel M
Respir Res; 2019 Jul; 20(1):170. PubMed ID: 31362723
[TBL] [Abstract][Full Text] [Related]
2. Measurement of C-reactive protein, procalcitonin and neutrophil elastase in saliva of COPD patients and healthy controls: correlation to self-reported wellbeing parameters.
Patel N; Belcher J; Thorpe G; Forsyth NR; Spiteri MA
Respir Res; 2015 May; 16(1):62. PubMed ID: 26018813
[TBL] [Abstract][Full Text] [Related]
3. Transient elevation of neutrophil proteinases in induced sputum during COPD exacerbation.
Ilumets H; Rytilä PH; Sovijärvi AR; Tervahartiala T; Myllärniemi M; Sorsa TA; Kinnula VL
Scand J Clin Lab Invest; 2008; 68(7):618-23. PubMed ID: 19378434
[TBL] [Abstract][Full Text] [Related]
4. Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD.
Thulborn SJ; Dilpazir M; Haldar K; Mistry V; Brightling CE; Barer MR; Bafadhel M
Int J Chron Obstruct Pulmon Dis; 2017; 12():1199-1205. PubMed ID: 28458531
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticosteroids differentially regulate MMP-9 and neutrophil elastase in COPD.
Vlahos R; Wark PA; Anderson GP; Bozinovski S
PLoS One; 2012; 7(3):e33277. PubMed ID: 22413009
[TBL] [Abstract][Full Text] [Related]
6. Proteinase 3 activity in sputum from subjects with alpha-1-antitrypsin deficiency and COPD.
Sinden NJ; Stockley RA
Eur Respir J; 2013 May; 41(5):1042-50. PubMed ID: 22936713
[TBL] [Abstract][Full Text] [Related]
7. MMP-8, MMP-9 and Neutrophil Elastase in Peripheral Blood and Exhaled Breath Condensate in COPD.
Sng JJ; Prazakova S; Thomas PS; Herbert C
COPD; 2017 Apr; 14(2):238-244. PubMed ID: 27880043
[TBL] [Abstract][Full Text] [Related]
8. Altered protease and antiprotease balance during a COPD exacerbation contributes to mucus obstruction.
Chillappagari S; Preuss J; Licht S; Müller C; Mahavadi P; Sarode G; Vogelmeier C; Guenther A; Nahrlich L; Rubin BK; Henke MO
Respir Res; 2015 Jul; 16(1):85. PubMed ID: 26169056
[TBL] [Abstract][Full Text] [Related]
9. Expressions of MMP-12, TIMP-4, and Neutrophil Elastase in PBMCs and Exhaled Breath Condensate in Patients with COPD and Their Relationships with Disease Severity and Acute Exacerbations.
Hao W; Li M; Zhang Y; Zhang C; Xue Y
J Immunol Res; 2019; 2019():7142438. PubMed ID: 31143784
[TBL] [Abstract][Full Text] [Related]
10. Moraxella catarrhalis acquisition, airway inflammation and protease-antiprotease balance in chronic obstructive pulmonary disease.
Parameswaran GI; Wrona CT; Murphy TF; Sethi S
BMC Infect Dis; 2009 Nov; 9():178. PubMed ID: 19912665
[TBL] [Abstract][Full Text] [Related]
11. Progranulin is a substrate for neutrophil-elastase and proteinase-3 in the airway and its concentration correlates with mediators of airway inflammation in COPD.
Ungurs MJ; Sinden NJ; Stockley RA
Am J Physiol Lung Cell Mol Physiol; 2014 Jan; 306(1):L80-7. PubMed ID: 24186875
[TBL] [Abstract][Full Text] [Related]
12. Profile of the ProAxsis active neutrophil elastase immunoassay for precision medicine in chronic respiratory disease.
Keir HR; Fong CJ; Dicker AJ; Chalmers JD
Expert Rev Mol Diagn; 2017 Oct; 17(10):875-884. PubMed ID: 28854829
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease.
Sethi S; Wrona C; Eschberger K; Lobbins P; Cai X; Murphy TF
Am J Respir Crit Care Med; 2008 Mar; 177(5):491-7. PubMed ID: 18079493
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of active neutrophil elastase in sputum of bronchiectasis and cystic fibrosis patients: A comparison among different techniques.
Oriano M; Terranova L; Sotgiu G; Saderi L; Bellofiore A; Retucci M; Marotta C; Gramegna A; Miglietta D; Carnini C; Marchisio P; Chalmers JD; Aliberti S; Blasi F
Pulm Pharmacol Ther; 2019 Dec; 59():101856. PubMed ID: 31626976
[TBL] [Abstract][Full Text] [Related]
15. The effect of azithromycin in adults with stable neutrophilic COPD: a double blind randomised, placebo controlled trial.
Simpson JL; Powell H; Baines KJ; Milne D; Coxson HO; Hansbro PM; Gibson PG
PLoS One; 2014; 9(8):e105609. PubMed ID: 25148049
[TBL] [Abstract][Full Text] [Related]
16. COPD is characterized by increased detection of Haemophilus influenzae, Streptococcus pneumoniae and a deficiency of Bacillus species.
Simpson JL; Baines KJ; Horvat JC; Essilfie AT; Brown AC; Tooze M; McDonald VM; Gibson PG; Hansbro PM
Respirology; 2016 May; 21(4):697-704. PubMed ID: 26781464
[TBL] [Abstract][Full Text] [Related]
17. Analysis of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients.
Paone G; Conti V; Vestri A; Leone A; Puglisi G; Benassi F; Brunetti G; Schmid G; Cammarella I; Terzano C
Dis Markers; 2011; 31(2):91-100. PubMed ID: 21897003
[TBL] [Abstract][Full Text] [Related]
18. Aα-Val360: a marker of neutrophil elastase and COPD disease activity.
Carter RI; Ungurs MJ; Mumford RA; Stockley RA
Eur Respir J; 2013 Jan; 41(1):31-8. PubMed ID: 22523359
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic stone protein predicts positive sputum bacteriology in exacerbations of COPD.
Scherr A; Graf R; Bain M; Christ-Crain M; Müller B; Tamm M; Stolz D
Chest; 2013 Feb; 143(2):379-387. PubMed ID: 22922487
[TBL] [Abstract][Full Text] [Related]
20. Systemic signs of neutrophil mobilization during clinically stable periods and during exacerbations in smokers with obstructive pulmonary disease.
Andelid K; Andersson A; Yoshihara S; Åhrén C; Jirholt P; Ekberg-Jansson A; Lindén A
Int J Chron Obstruct Pulmon Dis; 2015; 10():1253-63. PubMed ID: 26170654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
